Dr. John Freiberger and his wife Sharon join Diveheart President Jim Elliott and board member Mike Kaufmann for the third annual international adaptive scuba symposium. This year the focus was on the "Road to Research" as we move forward with Scuba Therapy.
Dr. Freiberger works on the translation of basic science research on reactive oxygen species signaling into clinical practice involving hyperbaric oxygen (HBO). He has performed animal experiments in the use of HBO for ischemic preconditioning and he is currently funded by Novartis Pharmaceuticals to conduct a randomized controlled trial of the use of HBO for the treatment of bisphosphonate-induced osteonecrosis of the jaw and by the Office of Naval Research to study the effects of hyper apnea and exercise at depth on cognition. The mechanisms of action for HBO in the treatment of: diabetic wounds, bony and soft tissue radio necrosis and decompression sickness are also areas of his inquiry. In the realm of diving medicine Dr Freiberger does basic epidemiological research into accidents and injuries associated with diving, high altitude exposure and other adverse environmental conditions. He is the Executive Director of Duke Dive Medicine and is currently serving his second term on the Board of Directors of the Undersea and Hyperbaric Medical Society. He is a yearly speaker at the NOAA / UHMS Physician’s Diving Medicine course and Course director for the UHMS Physician’s Fitness to Dive course.